Hinge Health, Inc. (HNGE) stock
HNGENYSEServices-Computer Processing & Data PreparationFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 11/30
$108.10−6.43 (-5.61%)
Close on Nov 19, 2026Market cap $8.72BP/E –Yield –
Hinge Health r&d expenses
Research and development expenses are spending on new products and technology.
Hinge Health's R&D Expenses for the twelve months ending Jun 30, 2026 was $129.07M, down 63.1% year over year. For fiscal 2025 it was $368.14M, up 265.1% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $368.14M | +265.1% |
| FY2024 | Dec 31, 2024 | $100.84M | -8.4% |
| FY2023 | Dec 31, 2023 | $110.06M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $34.06M | -87.8% |
| Q1 FY2026 | Mar 31, 2026 | $30.34M | +29.1% |
| Q4 FY2025 | Dec 31, 2025 | $32.76M | +46.4% |
| Q3 FY2025 | Sep 30, 2025 | $31.92M | +34.2% |
| Q2 FY2025 | Jun 30, 2025 | $279.96M | +1023.4% |
| Q1 FY2025 | Mar 31, 2025 | $23.50M | – |
| Q4 FY2024 | Dec 31, 2024 | $22.37M | – |
| Q3 FY2024 | Sep 30, 2024 | $23.79M | – |
| Q2 FY2024 | Jun 30, 2024 | $24.92M | – |
See a number that looks wrong?